• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大不列颠哥伦比亚省上皮性卵巢癌女性的长期死亡率:一项基于人群的研究。

Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada.

机构信息

Department of Obstetrics & Gynecology, University of British Columbia, Vancouver, BC, Canada.

Centre for Health Services and Policy Research, School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.

出版信息

BMC Cancer. 2018 Oct 25;18(1):1039. doi: 10.1186/s12885-018-4970-9.

DOI:10.1186/s12885-018-4970-9
PMID:30359249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6202883/
Abstract

OBJECTIVES

Among women with epithelial ovarian cancer (EOC), histotype is one of the major prognostic factors. However, few data are available on histotype- specific survival and mortality estimates among these patients. We therefore examined survival and causes of death among women with EOC by histotype.

METHODS

A population- based cohort including all ovarian cancer patients diagnosed in British Columbia (BC) between 1990 and 2014 was built using population-based administrative datasets. We compared causes of death within histotypes, by age at diagnosis, BRCA status, and time since diagnosis.

RESULTS

A total of 6975 women were identified as having been diagnosed with EOC between 1990 and 2014 in BC. The most common cause of death among these women was ovarian cancer until 10 years post diagnosis when other causes surpassed ovarian cancer as the leading cause of death. Among women with serous EOCs, ovarian cancer was the leading cause of death 12 years after diagnosis, whereas ovarian cancer was the leading cause of death for 8 years among women with non- serous EOCs. Among women with serous EOCs, ovarian cancer was the leading cause of death for 12 years among younger women (< 60 years of age) compared to 8 years among women > = 60 years of age, and those with BRCA mutations were more likely to die from ovarian cancer than those without a BRCA mutation.

CONCLUSIONS

Within 10 years from diagnosis, ovarian cancer is the leading cause of death among women diagnosed with EOC.

摘要

目的

在患有上皮性卵巢癌(EOC)的女性中,组织学类型是主要的预后因素之一。然而,关于这些患者的组织学类型特异性生存和死亡率估计数据很少。因此,我们通过组织学类型检查了患有 EOC 的女性的生存和死亡原因。

方法

使用基于人群的行政数据集构建了一个包括 1990 年至 2014 年期间在不列颠哥伦比亚省(BC)诊断出的所有卵巢癌患者的基于人群的队列。我们比较了不同组织学类型、诊断时年龄、BRCA 状态和诊断后时间内的死亡原因。

结果

共确定了 6975 名女性在 1990 年至 2014 年期间在 BC 被诊断为患有 EOC。这些女性中最常见的死亡原因是卵巢癌,直到诊断后 10 年,其他原因超过卵巢癌成为主要死亡原因。在患有浆液性 EOC 的女性中,卵巢癌是诊断后 12 年的主要死亡原因,而在非浆液性 EOC 的女性中,卵巢癌是主要死亡原因 8 年。在患有浆液性 EOC 的年轻女性(<60 岁)中,卵巢癌是 12 年内的主要死亡原因,而在年龄较大的女性(≥60 岁)中则为 8 年,且携带 BRCA 突变的女性比未携带 BRCA 突变的女性更有可能死于卵巢癌。

结论

在诊断后 10 年内,卵巢癌是诊断为 EOC 的女性的主要死亡原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2572/6202883/145d9109fd30/12885_2018_4970_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2572/6202883/410b187f8542/12885_2018_4970_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2572/6202883/145d9109fd30/12885_2018_4970_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2572/6202883/410b187f8542/12885_2018_4970_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2572/6202883/145d9109fd30/12885_2018_4970_Fig2_HTML.jpg

相似文献

1
Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada.加拿大不列颠哥伦比亚省上皮性卵巢癌女性的长期死亡率:一项基于人群的研究。
BMC Cancer. 2018 Oct 25;18(1):1039. doi: 10.1186/s12885-018-4970-9.
2
Causes of death among women with epithelial ovarian cancer by length of survival post-diagnosis: a population-based study in British Columbia, Canada.加拿大不列颠哥伦比亚省基于人群的研究:诊断后生存时间长短与上皮性卵巢癌女性死亡原因。
Int J Gynecol Cancer. 2019 Mar;29(3):593-598. doi: 10.1136/ijgc-2018-000040. Epub 2018 Dec 21.
3
Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers.BRCA 基因突变携带者的卵巢癌随访中的乳腺癌监测。
Am Surg. 2020 Oct;86(10):1243-1247. doi: 10.1177/0003134820964208. Epub 2020 Oct 26.
4
Use of an emulated trial to investigate the association between use of nitrogen-based bisphosphonates and risk of epithelial ovarian cancer.利用模拟试验研究含氮双膦酸盐的使用与上皮性卵巢癌风险之间的关联。
Int J Epidemiol. 2024 Jun 12;53(4). doi: 10.1093/ije/dyae108.
5
Predictors of survival trajectories among women with epithelial ovarian cancer.上皮性卵巢癌患者生存轨迹的预测因素。
Gynecol Oncol. 2020 Feb;156(2):459-466. doi: 10.1016/j.ygyno.2019.12.011. Epub 2019 Dec 12.
6
Cardiovascular medications and survival in people with ovarian cancer: A population-based cohort study from British Columbia, Canada.心血管药物与卵巢癌患者的生存:来自加拿大不列颠哥伦比亚省的一项基于人群的队列研究。
Gynecol Oncol. 2021 Aug;162(2):461-468. doi: 10.1016/j.ygyno.2021.05.021. Epub 2021 Jun 3.
7
Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21).意大利 BRCA 突变上皮性卵巢癌患者的特征和结局:一项回顾性多中心研究(MITO 21)。
Gynecol Oncol. 2021 Jun;161(3):755-761. doi: 10.1016/j.ygyno.2021.04.014. Epub 2021 Apr 20.
8
Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries.在 2 个癌症登记处中,具有生育能力保留手术的生殖年龄女性的上皮性卵巢癌的存活率。
Cancer. 2020 Mar 15;126(6):1217-1224. doi: 10.1002/cncr.32620. Epub 2019 Nov 27.
9
Prevalence of germline pathogenic variants in sequential epithelial ovarian cancer cases.连续上皮性卵巢癌病例中种系致病性变异的流行率。
J Med Genet. 2019 May;56(5):301-307. doi: 10.1136/jmedgenet-2018-105792. Epub 2019 Jan 25.
10
Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates.患有上皮性卵巢癌的年轻以色列女性:BRCA 突变的患病率及临床相关性。
J Gynecol Oncol. 2017 Sep;28(5):e61. doi: 10.3802/jgo.2017.28.e61. Epub 2017 Jun 5.

引用本文的文献

1
Epidemiological and clinicopathological characteristics of ovarian cancer in Syria during the war years: a national multicenter retrospective study (2017-2021).叙利亚战争期间卵巢癌的流行病学和临床病理特征:一项全国多中心回顾性研究(2017 - 2021年)
BMC Cancer. 2025 Aug 22;25(1):1359. doi: 10.1186/s12885-025-14784-8.
2
Expression of cyclooxygenase-2 (COX-2) in epithelial ovarian cancers in an Indigenous African population of Kano, Nigeria.尼日利亚卡诺州非洲原住民人群上皮性卵巢癌中环氧合酶-2(COX-2)的表达
Ecancermedicalscience. 2025 Feb 5;19:1838. doi: 10.3332/ecancer.2025.1838. eCollection 2025.
3
A Decade of Ovarian Cancer in Indonesia: Epidemiology and Survival Analysis from 2010 to 2020.

本文引用的文献

1
A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention.基于人群的分析显示,在针对卵巢癌预防的组织类型特异性方法时代,卵巢癌患者的种系 BRCA1 和 BRCA2 检测情况。
BMC Cancer. 2018 Mar 5;18(1):254. doi: 10.1186/s12885-018-4153-8.
2
Prophylactic mastectomy for BRCA mutation carriers after ovarian cancer treatment: is it beneficial?卵巢癌治疗后BRCA突变携带者的预防性乳房切除术:有益吗?
Expert Rev Anticancer Ther. 2018 Mar;18(3):199-200. doi: 10.1080/14737140.2018.1424547. Epub 2018 Jan 8.
3
Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?
印度尼西亚卵巢癌十年:2010年至2020年的流行病学与生存分析
J Clin Med. 2025 Mar 3;14(5):1692. doi: 10.3390/jcm14051692.
4
A Clinicopathological Study of Surface Epithelial Tumors of the Ovary: A Retrospective Analysis at a Tertiary Care Center in Jeddah, Saudi Arabia.卵巢表面上皮性肿瘤的临床病理研究:沙特阿拉伯吉达一家三级医疗中心的回顾性分析
Cureus. 2025 Jan 29;17(1):e78200. doi: 10.7759/cureus.78200. eCollection 2025 Jan.
5
Revolutionizing ovarian cancer therapy by drug repositioning for accelerated and cost-effective treatments.通过药物重新定位革新卵巢癌治疗,实现加速且具成本效益的治疗。
Front Oncol. 2025 Jan 14;14:1514120. doi: 10.3389/fonc.2024.1514120. eCollection 2024.
6
Establishment of an ovarian cancer exhausted CD8+T cells-related genes model by integrated analysis of scRNA-seq and bulk RNA-seq.通过单细胞 RNA-seq 和 bulk RNA-seq 整合分析建立卵巢癌耗竭 CD8+T 细胞相关基因模型。
Eur J Med Res. 2024 Jul 5;29(1):358. doi: 10.1186/s40001-024-01948-8.
7
Impact of Pre-Diagnostic Risk Factors on Short- and Long-Term Ovarian Cancer Survival Trajectories: A Longitudinal Observational Study.诊断前危险因素对卵巢癌短期和长期生存轨迹的影响:一项纵向观察性研究。
Cancers (Basel). 2024 Feb 28;16(5):972. doi: 10.3390/cancers16050972.
8
An assessment of survival outcomes among ovarian cancer patients at the National and Referral Hospital in Kenya.肯尼亚国家和转诊医院卵巢癌患者生存结果评估。
Cancer Rep (Hoboken). 2024 Feb;7(2):e1986. doi: 10.1002/cnr2.1986.
9
Stem Cell-Associated Signatures Help to Predict Diagnosis and Prognosis in Ovarian Serous Cystadenocarcinoma.干细胞相关特征有助于预测卵巢浆液性囊腺癌的诊断和预后。
Stem Cells Int. 2023 Apr 30;2023:4500561. doi: 10.1155/2023/4500561. eCollection 2023.
10
Clinicopathological Parameters Associated With Peritoneal Involvement in Epithelial Ovarian Tumors.上皮性卵巢肿瘤腹膜受累相关的临床病理参数
Cureus. 2023 Mar 25;15(3):e36666. doi: 10.7759/cureus.36666. eCollection 2023 Mar.
BRCA 突变携带者诊断为卵巢癌后患乳腺癌的风险:预防性乳房切除术是否必要?
Gynecol Oncol. 2017 May;145(2):346-351. doi: 10.1016/j.ygyno.2017.02.032. Epub 2017 Mar 14.
4
Competing causes of death in the head and neck cancer population.头颈部癌患者的竞争性死亡原因。
Oral Oncol. 2017 Feb;65:8-15. doi: 10.1016/j.oraloncology.2016.12.006. Epub 2016 Dec 18.
5
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2).卵巢癌的组织学:全球分布及对国际生存比较的影响(CONCORD-2)
Gynecol Oncol. 2017 Feb;144(2):405-413. doi: 10.1016/j.ygyno.2016.10.019. Epub 2016 Dec 6.
6
Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2).全球卵巢癌生存率比较:诊断时的组织学分组和分期(CONCORD-2)。
Gynecol Oncol. 2017 Feb;144(2):396-404. doi: 10.1016/j.ygyno.2016.11.019. Epub 2016 Dec 2.
7
Epidemiology of epithelial ovarian cancer.上皮性卵巢癌的流行病学
Best Pract Res Clin Obstet Gynaecol. 2017 May;41:3-14. doi: 10.1016/j.bpobgyn.2016.08.006. Epub 2016 Oct 3.
8
Ovarian carcinoma diagnosis: the clinical impact of 15 years of change.卵巢癌诊断:15年变化的临床影响
Br J Cancer. 2016 Oct 11;115(8):993-999. doi: 10.1038/bjc.2016.273. Epub 2016 Sep 15.
9
Ovarian cancer screening: could you recommend it? No.卵巢癌筛查:你会推荐它吗?不会。
Evid Based Med. 2016 Aug;21(4):134-5. doi: 10.1136/ebmed-2016-110385. Epub 2016 Jun 14.
10
Long-term mortality among women with epithelial ovarian cancer.上皮性卵巢癌女性的长期死亡率。
Gynecol Oncol. 2015 Aug;138(2):421-8. doi: 10.1016/j.ygyno.2015.06.005. Epub 2015 Jun 5.